TABLE 3.

Titration of the in vivo protection of anti-NiV MAbs^a

MAb	Quantity of MAb administered (μg)	% of surviving animals	Mean time of death (days)
None (control)		0	7.5
Nip GIP 1.7 (anti-NiV.G)	112	100
	1.12	100
	0.12	25	10.5
	0.012	25	12.5
	0.0012	25	9.5
Nip GIP 35 (anti-NiV.F)	180	100
	1.8	50	11.5
	0.18	0	7.75
	0.0.18	0	6.75
	0.0018	0	6.75

^aHamsters (four animals per group) were given dilutions of MAbs 24 h prior to and 1 h after receiving a lethal challenge of NiV.